Bollen Ilse A E, Ehler Elisabeth, Fleischanderl Karin, Bouwman Floor, Kempers Lanette, Ricke-Hoch Melanie, Hilfiker-Kleiner Denise, Dos Remedios Cristobal G, Krüger Martina, Vink Aryan, Asselbergs Folkert W, van Spaendonck-Zwarts Karin Y, Pinto Yigal M, Kuster Diederik W D, van der Velden Jolanda
Department of Physiology, VU University Medical Center, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Randall Division of Cell and Molecular Biophysics and Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, United Kingdom.
Am J Pathol. 2017 Dec;187(12):2645-2658. doi: 10.1016/j.ajpath.2017.08.022. Epub 2017 Sep 19.
Peripartum cardiomyopathy (PPCM) and dilated cardiomyopathy (DCM) show similarities in clinical presentation. However, although DCM patients do not recover and slowly deteriorate further, PPCM patients show either a fast cardiac deterioration or complete recovery. The aim of this study was to assess if underlying cellular changes can explain the clinical similarities and differences in the two diseases. We, therefore, assessed sarcomeric protein expression, modification, titin isoform shift, and contractile behavior of cardiomyocytes in heart tissue of PPCM and DCM patients and compared these with nonfailing controls. Heart samples from ischemic heart disease (ISHD) patients served as heart failure control samples. Passive force was only increased in PPCM samples compared with controls, whereas PPCM, DCM, and ISHD samples all showed increased myofilament Ca sensitivity. Length-dependent activation was significantly impaired in PPCM compared with controls, no impairment was observed in ISHD samples, and DCM samples showed an intermediate response. Contractile impairments were caused by impaired protein kinase A (PKA)-mediated phosphorylation because exogenous PKA restored all parameters to control levels. Although DCM samples showed reexpression of EH-myomesin, an isoform usually only expressed in the heart before birth, PPCM and ISHD did not. The lack of EH-myomesin, combined with low PKA-mediated phosphorylation of myofilament proteins and increased compliant titin isoform, may explain the increase in passive force and blunted length-dependent activation of myofilaments in PPCM samples.
围产期心肌病(PPCM)和扩张型心肌病(DCM)在临床表现上有相似之处。然而,尽管DCM患者无法恢复且病情会进一步缓慢恶化,但PPCM患者要么心脏迅速恶化,要么完全康复。本研究的目的是评估潜在的细胞变化是否能解释这两种疾病在临床方面的异同。因此,我们评估了PPCM和DCM患者心脏组织中心肌细胞的肌节蛋白表达、修饰、肌联蛋白异构体转换和收缩行为,并将这些与未发生心力衰竭的对照组进行比较。来自缺血性心脏病(ISHD)患者的心脏样本用作心力衰竭对照样本。与对照组相比,仅PPCM样本的被动力增加,而PPCM、DCM和ISHD样本的肌丝钙敏感性均增加。与对照组相比,PPCM样本的长度依赖性激活明显受损,ISHD样本未观察到受损,DCM样本表现出中间反应。收缩功能障碍是由蛋白激酶A(PKA)介导的磷酸化受损引起的,因为外源性PKA可将所有参数恢复到对照水平。尽管DCM样本显示出EH-肌间蛋白的重新表达,该异构体通常仅在出生前的心脏中表达,但PPCM和ISHD样本未出现这种情况。EH-肌间蛋白的缺乏,加上肌丝蛋白的低PKA介导的磷酸化和顺应性肌联蛋白异构体的增加,可能解释了PPCM样本中被动力的增加和肌丝长度依赖性激活的减弱。